VGEN

 
Common Stock
Grey Market
Contact Info
  • 949 Fell Street
  • Baltimore, MD 21231

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Latest Report Sep 30, 2015 10-Q
CIK 0001453001
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: MD, USA
Year of Inc. 2007
Employees 20 a/o Jun 07, 2016
Company Officers/Contacts
Peter Morsing COO
Eric Smith Securities Counsel
Earl Miller Finance Director, Asst. Treasurer
Company Directors
Michael G. Hanna Chairman Emeritus
Haka Edstrom
Michael Hagerman
Anders Hallidin
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
945 E Park Drive
Suite 103
Harrisburg, PA, 17111
United States
 
Securities Counsel
Venable LLP
750 East Pratt Street
Suite 900
Baltimore, MD, 21202
United States
 
Investor Relations Firm
Company History
  • 12(k) Suspension for the period commencing at 9:30 a.m. on September 26, 2017 and terminating at 11:59 p.m. EDT on October 9, 2017.
VGEN Security Details
Share Structure
Market Value1 $3,774 a/o Oct 20, 2017
Authorized Shares 200,000,000 a/o Apr 14, 2015
Outstanding Shares 37,736,041 a/o May 26, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 10,001,329 a/o May 23, 2016
Par Value 0.0001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 255 (0%)
May 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security